QIAGEN NV's ticker is and the CUSIP is N72482AA5. A total of 19 filers reported holding QIAGEN NV in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $38,236,000 | +8.8% | 29,800,000 | 0.0% | 0.14% | +3.7% |
Q1 2018 | $35,134,000 | +1.8% | 29,800,000 | 0.0% | 0.14% | +3.0% |
Q4 2017 | $34,511,000 | -0.2% | 29,800,000 | 0.0% | 0.13% | -7.7% |
Q3 2017 | $34,563,000 | +25.0% | 29,800,000 | +31.9% | 0.14% | +11.7% |
Q2 2017 | $27,658,000 | – | 22,600,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Myriad Asset Management Ltd. | 30,000,000 | $39,938,000 | 5.76% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 39,600,000 | $52,585,000 | 3.15% |
Mint Tower Capital Management B.V. | 19,000,000 | $25,200,000 | 3.12% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 41,800,000 | $55,338,000 | 1.31% |
Lombard Odier Asset Management (Europe) Ltd | 4,800,000 | $6,352,000 | 0.44% |
SSI INVESTMENT MANAGEMENT LLC | 3,000,000 | $3,960,000 | 0.30% |
Verition Fund Management LLC | 50,000 | $6,610,000 | 0.24% |
CQS Cayman LP | 3,800,000 | $5,028,000 | 0.24% |
SG Americas Securities, LLC | 128,000 | $16,954,000 | 0.13% |
EXANE DERIVATIVES | 1 | $266,612,000 | 0.05% |